Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Isoray, Inc. | isr20200630_10k.htm |
| EX-32 - EXHIBIT 32 - Isoray, Inc. | ex_187759.htm |
| EX-31.3 - EXHIBIT 31.3 - Isoray, Inc. | ex_187758.htm |
| EX-31.2 - EXHIBIT 31.2 - Isoray, Inc. | ex_187757.htm |
| EX-31.1 - EXHIBIT 31.1 - Isoray, Inc. | ex_187756.htm |
| EX-23.1 - EXHIBIT 23.1 - Isoray, Inc. | ex_187755.htm |
| EX-21.1 - EXHIBIT 21.1 - Isoray, Inc. | ex_187754.htm |
| EX-10.54 - EXHIBIT 10.54 - Isoray, Inc. | ex_187752.htm |
Exhibit 10.55
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
Addendum No. 2 dated July 12, 2020 to
Contract No. 840/08625142/31/92-19
dd: 2019.07.31
THE SELLER
Joint Stock Company «Isotope»,
(JSC «Isotope»)
Pogodinskaya str., 22, Moscow, 119435, Russia.
Phone: +7(495) 981-96-16.
THE BUYER
The Company Isoray Medical Inc.
350 Hills Street, Suite 106
Richland, WA 99354-5411 USA
THE BUYER and THE SELLERS have mutually agreed about the following:
|
1. |
The total activity of shipments under the Contract on calibration date is increased on [**] and is equal to [**]. |
| 2. | The total amount of the Ñontract is increased on USD [**] and is equal to USD [**]. |
All other terms and conditions are in accordance with Contract No. 840/08625142/31/92-19, Appendices 1 and 2, Addendum 1. The present Addendum 2 is an integral part of the Contract and may be signed via E-mail.
| THE SELLER | THE BUYER | ||
| /s/ Anton Shargin | /s/ Jennifer Streeter | ||
| Anton Shargin | Jennifer Streeter | ||
| Director of Department of Isotope Product Sales | 14 Aug 2020 | ||
| JSC Isotope | Isoray - COO |